Novartis to slash nearly 2,000 U.S. jobs
2012/01/13 02:03:16 @Reuters: Top News
ZURICH (Reuters) - Novartis AG is cutting nearly 2,000 jobs in the United States ahead of the patent loss of top-selling blood pressure drug Diovan as it braces for tough market conditions and a slump in sales of another key drug. [ VIEW FULL COVERAGE @Reuters: Top News ]